Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases – specifically, chronic obstructive pulmonary disease (COPD) and asthma.
“This is just the beginning of our journey to transform respiratory care.” A recent report from Persistence Market Research concluded that the global market for smart inhaler devices that ...
Canada 2 Division of Respiratory Medicine, McGill University Health Centre Correspondence to: Dr S Suissa, Division of Clinical Epidemiology, Royal Victoria Hospital, 687 Pine Avenue West, Ross 4.29, ...